Drugs News and Research

RSS

Transition in the management of COVID-19

A review of the current approaches to managing COVID-19, including diagnostic, therapeutic, and preventive measures.

16 Oct 2022

In silico studies identify potent plant metabolites capable of inhibiting SARS-CoV-2

In silico studies assess the binding efficacy of phytoconstituents against active sites of SARS-CoV-2.

16 Oct 2022

Study finds a possible new target to fight osteoarthritis

Wear and tear on joints can lead to inflammation, breakdown of cartilage and development of osteoarthritis.

14 Oct 2022

Research sheds light on specific protein interaction that could provide new treatment strategy to combat Cholera

Bacterial infectious diseases are still a huge contributor to global disease burden and with antibiotic resistance on the rise worldwide there is an urgent need for novel treatment strategies against bacteria.

14 Oct 2022

SARS-CoV-2 envelope structural protein found to form voltage-activated and calcium-activated calcium channels

In a new study, researchers investigated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) envelope (E) protein activity in terms of calcium cations (Ca2+) cations.

14 Oct 2022

Pain-sensing neurons protect the gut from inflammation and associated tissue damage

Neurons that sense pain protect the gut from inflammation and associated tissue damage by regulating the microbial community living in the intestines, according to a study from researchers at Weill Cornell Medicine.

14 Oct 2022

Study determines how fibroblasts play a role in tumor's ability to generate anti-HER2 therapy resistance

A study led by researchers at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) has determined the role that fibroblasts, the cells that contribute to tissue formation, play in a tumor's ability to generate resistance to the most common biological treatment for HER2.

14 Oct 2022

Multi-center analysis shines light on invasive lobular carcinoma

A multi-center analysis of patients with invasive lobular carcinoma, or ILC - the second most common histological subtype of invasive breast cancer in the U.S. - showed that, despite its prevalence, ILC is detected later and has worse outcomes than the predominant subtype of invasive breast cancer, known as invasive ductal carcinoma (IDC), or no special type.

14 Oct 2022

Study illuminates how pain neurons protect the gut from damage

Pain has been long recognized as one of evolution's most reliable tools to detect the presence of harm and signal that something is wrong - an alert system that tells us to pause and pay attention to our bodies.

14 Oct 2022

Rheumatoid arthritis drug can be repurposed to improve diabetes-associated symptoms

Researchers at Baylor College of Medicine and collaborating institutions discovered that the rheumatoid arthritis drug auranofin can potentially be repurposed to improve diabetes-associated symptoms.

14 Oct 2022

Review on Panax ginseng therapeutic efficacy for COVID-19-associated neurological diseases

In a new study, researchers discussed the therapeutic potential of Panax ginseng for COVID-19 (coronavirus disease 2019)-induced neurological diseases.

14 Oct 2022

Will covid spike again this fall? 6 tips to help you stay safe

Last year, the emergence of the highly transmissible omicron variant of the covid-19 virus caught many people by surprise and led to a surge in cases that overwhelmed hospitals and drove up fatalities. Now we're learning that omicron is mutating to better evade the immune system.

14 Oct 2022

Weight loss gadgets: They provide data to help consumers achieve diet goals, but it still won’t be easy

I felt a special kind of awe, then panic, watching my glucose levels skyrocket for the first time after relishing a cold beer on a sweltering summer evening.

14 Oct 2022

Associations of cardioprotective medications with COVID-19 outcomes

Researchers evaluated COVID-19 outcomes in patients taking four types of cardioprotective medicines.

14 Oct 2022

Widespread availability of polypills could reduce the risk of cardiovascular disease, Say cardiologists

Global health has paid a deadly price for not using simple, low-cost blood pressure lowering drugs, statins and aspirin widely in the form of a single pill, also known as the polypill, say two leading cardiologists in a commentary published in The Lancet.

14 Oct 2022

Flatworm-inspired medical adhesives halt non-compressible hemorrhage

Every year around 2 million people die worldwide from hemorrhaging or blood loss. Uncontrolled hemorrhaging accounts for more than 30% of trauma deaths.

13 Oct 2022

Experimental cancer drug shows promise as a treatment for idiopathic pulmonary fibrosis

Researchers have shown that the medication saracatinib shows promise as a treatment for idiopathic pulmonary fibrosis (IPF).

13 Oct 2022

$1.91 million grant to explore human internal "clock” as a tool for optimizing tissue regeneration

The human internal "clock" responsible for regulating sleep cycles and many other biological functions will be explored as a tool for optimizing tissue regeneration under a $1.91 million grant University of Massachusetts Amherst biomedical engineer and assistant professor Cathal Kearney has received from the National Institutes of Health's National Institute of General Medical Sciences.

13 Oct 2022

KHN’s ‘What the Health?’: Finally fixing the ‘family glitch’

The Biden administration this week issued regulations aimed at fixing the Affordable Care Act's "family glitch," which has prevented families that can't afford their employer insurance from getting subsidized coverage from the insurance marketplaces.

13 Oct 2022

Motif-based SARS-CoV-2 protein-human protein interactions as potential antiviral target sites

Researchers performed a ProP-PD (proteomic peptide phage display) analysis to identify peptides from intrinsically disordered human (host) proteome regions that bind with SARS-CoV-2 genome-encoded folded protein domains (PDs).

13 Oct 2022

Drugs News and Research

Transition in the management of COVID-19

In silico studies identify potent plant metabolites capable of inhibiting SARS-CoV-2

Study finds a possible new target to fight osteoarthritis

Research sheds light on specific protein interaction that could provide new treatment strategy to combat Cholera

SARS-CoV-2 envelope structural protein found to form voltage-activated and calcium-activated calcium channels

Pain-sensing neurons protect the gut from inflammation and associated tissue damage

Study determines how fibroblasts play a role in tumor's ability to generate anti-HER2 therapy resistance

Multi-center analysis shines light on invasive lobular carcinoma

Study illuminates how pain neurons protect the gut from damage

Rheumatoid arthritis drug can be repurposed to improve diabetes-associated symptoms

Review on Panax ginseng therapeutic efficacy for COVID-19-associated neurological diseases

Will covid spike again this fall? 6 tips to help you stay safe

Weight loss gadgets: They provide data to help consumers achieve diet goals, but it still won’t be easy

Associations of cardioprotective medications with COVID-19 outcomes

Widespread availability of polypills could reduce the risk of cardiovascular disease, Say cardiologists

Flatworm-inspired medical adhesives halt non-compressible hemorrhage

Experimental cancer drug shows promise as a treatment for idiopathic pulmonary fibrosis

$1.91 million grant to explore human internal "clock” as a tool for optimizing tissue regeneration

KHN’s ‘What the Health?’: Finally fixing the ‘family glitch’

Motif-based SARS-CoV-2 protein-human protein interactions as potential antiviral target sites

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News